Hear from Steve Barnard about the latest Illumina innovations from library prep, sequencing, and analysis and learn how we are enabling transformative applications using multiomics. Niall Lennon, PhD from the Broad Institute of MIT will join Steve to provide insights into new Illumina technology.
Steve Barnard, PhD Chief Technology Officer
Illumina
Niall Lennon, PhD Chair and Chief Scientific Officer
Broad Clinical Labs, MIT
Through its participation in KSLM, Illumina aims to strengthen direct engagement with clinical laboratory professionals and share its value as a trusted long-term partner supporting the next generation of precision diagnostics.
Through its participation in the KSMG Spring Meeting, Illumina aims to share a practical roadmap for extending genomic studies from focused exome analysis to comprehensive whole-genome research, supporting continued progress in genetic disease research.